New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
CLS Holdings USA, Inc.
CLSH
Shape
US Flag

PNK

Unprofitable

Unprofitable

8M

Drug Manufacturers - Specialty & Generic

Next Earning date - 09 Jan 2025

8M

Drug Manufacturers - Specialty & Generic

Next Earning date - 09 Jan 2025

0.05USD
Shape0.00 ( 6.38%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-97%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

17%

Quote Panel

Shape
Updated October 16, 2024
1W 12.28 % 1M 4.38 % 3M 29.53 % 1Y 0.00 %

Key Metrics

Shape
  • Market Cap

    8.29M


  • Shares Outstanding

    165.86M


  • Share in Float

    127.32M


  • Dividende

    0


  • Earning Date

    09 Jan 2025


  • Price Target

    0.05


  • Average Volume

    15469


  • Beta

    1.319


  • Range

    0.0267-0.06


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.clsholdingsinc.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.42x

P/S Ratio

-0.54x

P/B Ratio

-0.8

Debt/Equity

-24.7%

Net Margin

$-0.1

EPS

How CLSH compares to sector?

P/E Ratio

Relative Strength

Shape

CLSH

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

N/A

-0.05
vs -0.32

Q3.22

arrow
arrow

N/A

-0.04
vs 0.01

Q4.22

arrow
arrow

N/A

-0.12
vs -0.01

Q1.23

arrow
arrow

N/A

-0.01
vs -0.03

Q2.23

arrow
arrow

N/A

-0.05
vs -0.05

Q3.23

arrow
arrow

N/A

-0.01
vs -0.04

Q4.23

arrow
arrow

N/A

-0.02
vs -0.12

Q1.24

arrow
arrow

N/A

-0.04
vs -0.01

Q2.24

arrow
arrow

+134%

0.02
vs -0.05

Q3.24

arrow
arrow

N/A

-0.01
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

+2%

6.2M  vs 6.1M

Q3.22

arrow
arrow

+10%

6M  vs 5.5M

Q4.22

arrow
arrow

+12%

6.1M  vs 5.4M

Q1.23

arrow
arrow

-3%

5.4M  vs 5.6M

Q2.23

arrow
arrow

-9%

5.6M  vs 6.2M

Q3.23

arrow
arrow

-100%

100  vs 6M

Q4.23

arrow
arrow

-14%

5.2M  vs 6.1M

Q1.24

arrow
arrow

-9%

4.9M  vs 5.4M

Q2.24

arrow
arrow

-15%

4.7M  vs 5.6M

Q3.24

arrow
arrow

+4805065%

4.8M  vs 100

Return on EquityShape

status-upQoQ

Q4.22

arrow
arrow

+100%

1
vs 0.07

Q1.23

arrow
arrow

+11%

0.11
vs 1

Q2.23

arrow
arrow

+28%

0.28
vs 0.11

Q3.23

arrow
arrow

+4%

0.04
vs 0.28

Q4.23

arrow
arrow

+9%

0.09
vs 0.04

Q1.24

arrow
arrow

+42%

0.42
vs 0.09

Q2.24

arrow
arrow

-14%

-0.14
vs 0.42

Q3.24

arrow
arrow

+7%

0.07
vs -0.14

Institutionnal OwnershipShape

status-upQoQ

Q3.18

arrow
arrow

1

1
vs NA

NA

Earnings Growth

Latest News